Skip to content

Who We Are

We offer a combination of services to constitute your most beneficial financing mix

About Us

FFUND was founded by a group of experienced entrepreneurs with a common vision to accelerate the translation of innovation in the life science industry. Our goal is to convert years of business and product development experience into an end-to-end solution for our customers. We focus on successfully sucuring the financing mix, including European non-dilutive funding, equity financing, and deals.

Currently we served over 280 Life Science start-ups, SMEs, and Universities in the EU with a range of consulting services primarily focused on strategic funding and M&A activities. We are on the journey to build an EU-wide network to foster leading innovations in 4 domains: Therapeutics, MedTech, Diagnostics, and Digital Health.

Area’s of Expertise

Diagnostics
Medtech
Therapeutics
Digital Health
“We leverage our scientific and business background to support companies in becoming investor ready, close strong deals and create value.”
Dr. Judith Smit
CEO
“We have experienced the challenges that our clients are faced with and can help them to become successful.”
Dr. Henk Viëtor
CBO

Our Story

“Life sciences is a unique segment, where niche sector expertise is critical for providing effective consulting support”

Dr. Judith J. Smit (CEO) and Dr. Henk Viëtor (CBO)

AS_FFund_Amsterdam_20220202_0783-800x1045

The life science sector is experiencing prosperous growth. Numerous new technologies are invented and valorised every year. The demand for translating technologies from the lab bench to the clinic is very high, while the path to success is challenged with many scientific, regulatory and financial hurdles.

At FFUND, we bring over 60 years of combined entrepreneurial experience in the segment to help our clients accelerate their R&D roadmap, with the ambition to enable more technologies to reach the market. We support them as a true “impact partner” with a solid know-how of the sector dynamics, financing opportunities, technical expertise and a network of stakeholders.

We are convinced that a balanced financing mix (non-dilutive, loans and equity) is crucial for a successful life sciences company. FFUND is the partner to unburden our clients with this complex task and secure a successful financing strategy. We are an end-to-end partner, covering our client’s financing need from start-up to commercialization or exit.

AS_FFund_Amsterdam_20220202_0783-800x1045

Why our clients choose FFUND

An end-to-end service proposition for all stages of your growth and exit
Life Sciences experts

As entrepreneurs we understand the Life Science development and funding roadmap by personal experience. We strive to be your sparring partner throughout your growth trajectory and towards a lucrative exit.

Strategy

We know which funding instruments and strategies are best fitted for each development step. Based on your product development needs and vision for the future, together we can determine the most appropriate funding and exit strategy for your company.

Partnerships

Successful life sciences companies use a complex mix of equity and non-dilutive funding instruments. Non-dilutive funding reduces the dilution of shares, while it provides an excellent opportunity to establish valuable partnerships and external validation of the company and technology.

Specialists

FFUND boutique consulting is specialized to help innovators in the life sciences to plan, secure and coordinate the optimal financing mix and fund their project from start-up to successful exit. We save your valuable time and increase the chance success.

280+

Clients served worldwide

€500M +

Funding raised across all stages of innovation growth

260+

Clients in the EU

Global Network

Acces to network of global investors, large Pharma/Med Tech players and innovation ecosystems

Our Team

Meet our experts

We bring the right people together to challenge established thinking and drive transformation.

FFUND Experts